The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 8.18 — safe zoneOK
- Earnings-manipulation signal · Beneish M -2.65 — no flag raisedOK
- Earnings quality 84/100 — accruals in line with cashOK
Leadership changes
From LEMAITRE VASCULAR INC's own filings, the day they're filed.
- Bridget Ross · Directors · departureeff. 2026-04-08
- LumiraDx Limited · Chief Financial Officer · appointment
Latest filings
- 8-K · Company announcement2026-06-05
- 10-Q · Quarterly report2026-05-06
- 8-K · Company announcement2026-05-05
- DEF 14A · Annual proxy (pay & governance)2026-04-14
- 8-K · Company announcement2026-04-14
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about LEMAITRE VASCULAR INC, every answer cited🔒
- The Intelligence Brief — added when LEMAITRE VASCULAR INC's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.